Biogen Inc.
BIIB
$181.54
$0.790.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.79% | 7.33% | 6.13% | 2.87% | -2.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.79% | 7.33% | 6.13% | 2.87% | -2.55% |
| Cost of Revenue | -13.84% | -1.00% | 16.02% | -5.63% | -10.51% |
| Gross Profit | 8.03% | 12.60% | 3.39% | 5.84% | 0.26% |
| SG&A Expenses | 2.61% | 5.63% | -0.64% | 11.61% | -23.25% |
| Depreciation & Amortization | 23.25% | 46.61% | 42.78% | 45.17% | 80.79% |
| Other Operating Expenses | 25.83% | 20.19% | -11.43% | 5.16% | 37.23% |
| Total Operating Expenses | -5.32% | 4.50% | 5.49% | 1.13% | -17.93% |
| Operating Income | 27.41% | 13.11% | 7.83% | 10.11% | 125.91% |
| Income Before Tax | 23.57% | 6.48% | -33.05% | -0.03% | 419.41% |
| Income Tax Expenses | 45.28% | -5.13% | -0.98% | -41.92% | 185.73% |
| Earnings from Continuing Operations | 20.08% | 8.77% | -38.87% | 7.15% | 668.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.08% | 8.77% | -38.87% | 6.81% | 670.48% |
| EBIT | 27.41% | 13.11% | 7.83% | 10.11% | 125.91% |
| EBITDA | 23.54% | 14.61% | 10.92% | 15.05% | 100.73% |
| EPS Basic | 19.34% | 8.11% | -39.24% | 6.22% | 666.96% |
| Normalized Basic EPS | 33.47% | 13.42% | 13.32% | 9.59% | 92.20% |
| EPS Diluted | 19.17% | 8.25% | -39.26% | 6.30% | 665.60% |
| Normalized Diluted EPS | 33.39% | 13.50% | 13.47% | 9.89% | 91.67% |
| Average Basic Shares Outstanding | 0.62% | 0.62% | 0.62% | 0.55% | 0.62% |
| Average Diluted Shares Outstanding | 0.68% | 0.55% | 0.48% | 0.27% | 0.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |